telmisartan actavis
actavis group ptc ehf - telmisartan - hipertensão - agentes que atuam no sistema renina-angiotensina - hypertensiontreatment da hipertensão essencial em adultos. sistema circulatório preventionreduction de morbidade cardiovascular em pacientes com:manifesto aterotrombóticos doença cardiovascular (história de doença coronariana, acidente vascular cerebral ou doença arterial periférica) ou;diabetes mellitus tipo 2 com documentados danos em órgãos-alvo.
tolura
krka, d.d., novo mesto - telmisartan - hipertensão - antagonistas de angiotensina ii, - hypertensiontreatment da hipertensão essencial em adultos. sistema circulatório preventionreduction de morbidade cardiovascular em pacientes com:manifesto aterotrombóticos doença cardiovascular (história de doença coronariana ou doença arterial periférica) ou;diabetes mellitus tipo 2 com documentados danos em órgãos-alvo.
xeljanz
pfizer europe ma eeig - tofacitinib - artrite, reumatóide - imunossupressores - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 e 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
ampicilina
brainfarma indÚstria quÍmica e farmacÊutica s.a - ampicilina anidra - penicilina de amplo espectro
bissulfato de clopidogrel
fundaÇÃo para o remÉdio popular - furp - bissulfato de clopidogrel - outros medicamentos de acao no aparelho cardiovascular
bissulfato de clopidogrel
sandoz do brasil indÚstria farmacÊutica ltda - bissulfato de clopidogrel - outros medicamentos de acao no aparelho cardiovascular
bissulfato de clopidogrel
sanofi medley farmacÊutica ltda. - bissulfato de clopidogrel - outros medicamentos de acao no aparelho cardiovascular
clopin
achÉ laboratÓrios farmacÊuticos s.a - bissulfato de clopidogrel - outros medicamentos de acao no aparelho cardiovascular
clopiplax
germed farmaceutica ltda - bissulfato de clopidogrel - outros medicamentos de acao no aparelho cardiovascular
clopivix
dr. reddys farmacÊutica do brasil ltda - bissulfato de clopidogrel - outros medicamentos de acao no aparelho cardiovascular